Urology at Huashan Hospital Shanghai | CMCS

Expert Urological Care at One of China's Premier Academic Medical Centers

The Department of Urology at Huashan Hospital — affiliated with Fudan University — is one of China's most distinguished urology centers, with a national reputation for excellence in urological oncology, minimally invasive and robotic urological surgery, benign prostatic conditions, urinary stone disease, and functional urology. The department combines outstanding clinical expertise with a productive research program, offering international patients access to some of China's most eminent urologists and the latest evidence-based treatments for complex urological conditions.

For international patients seeking expert urological care in Shanghai — whether for prostate cancer, bladder cancer, kidney cancer, kidney stones, or a complex functional urological condition — Huashan Hospital's urology department represents one of the most compelling destinations in Asia. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.

About the Department

Huashan Hospital's urology department is a national key clinical specialty operating dedicated urological wards, a robotic and minimally invasive surgical theater, a urodynamics laboratory, a stone treatment center with shock wave lithotripsy and endoscopic stone surgery, and subspecialty clinics for urological oncology, benign prostatic disease, urinary stone disease, and functional urology. The department works in close collaboration with oncology, radiation oncology, and pathology through a dedicated urological oncology MDT.

Faculty members publish regularly in leading urology journals including European Urology, Journal of Urology, BJU International, and Urology.

Conditions Treated

Urological Oncology

• Prostate Cancer — Active surveillance for low-risk disease; robotic-assisted radical prostatectomy (RARP); radiation therapy coordination; androgen deprivation therapy; novel hormonal agents (enzalutamide, apalutamide, darolutamide) for non-metastatic CRPC; abiraterone and enzalutamide for metastatic CRPC; PARP inhibitors (olaparib, rucaparib) for HRR-mutated mCRPC; lutetium-177 PSMA therapy coordination
• Bladder Cancer — TURBT for non-muscle-invasive bladder cancer; intravesical BCG and chemotherapy; robotic radical cystectomy with neobladder or ileal conduit; neoadjuvant chemotherapy; pembrolizumab and atezolizumab for advanced urothelial carcinoma; enfortumab vedotin and sacituzumab govitecan
• Kidney Cancer (Renal Cell Carcinoma) — Robotic partial nephrectomy for nephron-sparing surgery; radical nephrectomy; ablative therapies (RFA, cryoablation) for small renal masses; sunitinib, pazopanib, cabozantinib, and nivolumab + ipilimumab for metastatic RCC; belzutifan for VHL-associated RCC
• Upper Tract Urothelial Carcinoma — Ureteroscopic management and radical nephroureterectomy; erdafitinib for FGFR-altered disease
• Testicular Cancer — Radical orchiectomy; retroperitoneal lymph node dissection (RPLND); BEP chemotherapy; surveillance protocols
• Penile Cancer — Organ-sparing surgery and partial/total penectomy; inguinal lymph node dissection
• Adrenal Tumors — Laparoscopic and robotic adrenalectomy for pheochromocytoma, aldosteronoma, and adrenocortical carcinoma

Benign Prostatic Disease

• Benign Prostatic Hyperplasia (BPH) — Medical management (alpha-blockers, 5-ARIs, PDE5 inhibitors); minimally invasive procedures (Rezum water vapor therapy, UroLift); TURP and laser enucleation (HoLEP) for larger glands
• Prostatitis — Acute and chronic bacterial prostatitis; chronic pelvic pain syndrome management
• Prostate-Specific Antigen (PSA) Elevation — Systematic and MRI-targeted prostate biopsy; risk stratification and management

Urinary Stone Disease

• Kidney Stones — Shock wave lithotripsy (SWL); ureteroscopy with laser lithotripsy; percutaneous nephrolithotomy (PCNL) for large stones; metabolic evaluation and stone prevention
• Ureteral Stones — Medical expulsive therapy; ureteroscopy with laser lithotripsy
• Bladder Stones — Cystoscopic lithotripsy and open cystolithotomy
• Staghorn Calculi — PCNL and combination approaches for complex staghorn stones

Functional Urology

• Overactive Bladder & Urge Incontinence — Behavioral therapy, antimuscarinics, beta-3 agonists (mirabegron, vibegron); botulinum toxin injection; sacral neuromodulation (InterStim)
• Stress Urinary Incontinence — Pelvic floor physiotherapy; mid-urethral sling (TVT, TOT); bulking agents
• Neurogenic Bladder — Clean intermittent catheterization; botulinum toxin; sacral neuromodulation; augmentation cystoplasty
• Urethral Stricture — Urethral dilation, direct vision internal urethrotomy (DVIU), and urethroplasty
• Pelvic Organ Prolapse — Pelvic floor repair and sacrocolpopexy in collaboration with gynecology

Male Sexual & Reproductive Health

• Erectile Dysfunction — PDE5 inhibitors; vacuum erection devices; penile prosthesis implantation
• Male Infertility — Semen analysis and hormonal evaluation; varicocelectomy; microsurgical sperm retrieval (TESE, MESA) for azoospermia; IVF/ICSI coordination
• Peyronie's Disease — Collagenase injection (Xiaflex) and surgical correction
• Hypogonadism — Testosterone replacement therapy; fertility-preserving hormonal stimulation

Reconstructive Urology

• Urinary Diversion — Ileal conduit, continent cutaneous diversion, and orthotopic neobladder after cystectomy
• Ureteral Reconstruction — Ureteral reimplantation, Boari flap, and ileal ureter for ureteral strictures
• Fistula Repair — Vesicovaginal and ureterovaginal fistula repair

Robotic & Minimally Invasive Urology

Huashan's urology department has been at the forefront of robotic and minimally invasive urological surgery adoption in China, offering:

• Robotic-Assisted Radical Prostatectomy (RARP) — da Vinci robotic prostatectomy with nerve-sparing technique for potency preservation; one of Shanghai's most experienced RARP programs
• Robotic Partial Nephrectomy — Nephron-sparing surgery for renal tumors with robotic precision; zero ischemia techniques for renal function preservation
• Robotic Radical Cystectomy — Intracorporeal neobladder construction; reduced blood loss and faster recovery
• Robotic Adrenalectomy — For pheochromocytoma and other adrenal tumors
• Holmium Laser Enucleation of the Prostate (HoLEP) — Size-independent laser enucleation for BPH; superior to TURP for large glands
• Flexible Ureteroscopy with Laser Lithotripsy — Single-use digital flexible ureteroscopes for kidney and ureteral stone treatment

Urological Oncology MDT

All urological cancer cases at Huashan are reviewed by the urological oncology MDT, integrating urological, oncological, radiation oncological, radiological, and pathological expertise to develop personalized treatment plans. The MDT is particularly important for:

• Prostate cancer — active surveillance vs. radical treatment; surgical vs. radiation therapy; sequencing of novel hormonal agents
• Bladder cancer — bladder preservation vs. radical cystectomy; neoadjuvant chemotherapy selection
• Kidney cancer — partial vs. radical nephrectomy; ablation vs. surgery for small renal masses; systemic therapy sequencing for metastatic RCC

Why International Patients Choose Huashan Urology

• Robotic Surgery Expertise — One of Shanghai's most experienced robotic urology programs for prostatectomy, partial nephrectomy, and cystectomy
• Urological Oncology MDT — Multidisciplinary tumor board ensuring personalized, evidence-based cancer treatment planning
• Novel Therapy Access — PARP inhibitors, PSMA-targeted therapy, and novel immunotherapy combinations for advanced urological cancers
• Comprehensive Stone Program — Full range of SWL, ureteroscopy, and PCNL for all stone types and sizes
• Functional Urology Expertise — Sacral neuromodulation, botulinum toxin, and reconstructive urology for complex functional conditions
• Cost-Effectiveness — World-class urological care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your urological history, PSA results, imaging (CT, MRI, ultrasound), biopsy reports, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate urologist based on your condition — oncology, stone disease, BPH, functional urology, or male reproductive health.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Huashan Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
7. Diagnostic & Surgical Support — Full coordination of prostate biopsy, urodynamics, imaging, and surgical admission.
8. Post-Treatment Follow-Up — Pathology report translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert urological care in Shanghai — whether for prostate cancer, bladder cancer, kidney cancer, kidney stones, BPH, or a complex functional urological condition — CMCS can arrange a specialist consultation with Huashan Hospital's urology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com